SSRIs

What SSRIs are

SSRIs are a class of medication used to treat depression and a range of anxiety-related conditions. The class includes several drugs that share the same basic mechanism: fluoxetine, sertraline, escitalopram, citalopram, paroxetine, and fluvoxamine are the most commonly prescribed. They differ in dosing, in how long they stay in the body, in their side effect tendencies, and in how they interact with other drugs, but they work in broadly the same way. This page is an overview of the class. For drug-by-drug detail, including dosing and how the individual medications compare, see the plain-language guides at PsychiatryRx.org.

The word "selective" does real work in the name. Older antidepressants, the tricyclics and the monoamine oxidase inhibitors, act on several brain chemical systems at once, which made them effective but harder to tolerate and more dangerous in overdose. SSRIs were designed to act mainly on one system, serotonin, and leave the others largely alone. That selectivity is the main reason they tend to be better tolerated and far safer if someone takes too much, and a big part of why they became the default starting point for treating depression and anxiety.

It helps to be clear about what an SSRI isn't. It isn't a sedative or tranquilizer, and it doesn't produce a calm feeling within an hour the way a benzodiazepine or a glass of wine might. It isn't a stimulant or a painkiller. It treats an underlying condition over time rather than masking distress in the moment. And it isn't a personality drug. When it helps, it turns down the depression or the anxiety so the person underneath has more room.

### The SSRIs at a glance

How they work

Serotonin is one of the brain's chemical messengers. Nerve cells release it into the small gap between cells, called the synapse, where it carries a signal to the next cell. After it has done that job, much of the serotonin is pumped back into the cell that released it, a process called reuptake, so it can be used again. SSRIs block that pump. By slowing reuptake, they leave more serotonin available in the synapse for longer. That much is well established, and it's where the name comes from. You can see how SSRIs work at the synapse in PsychiatryRx's interactive guide, with the medication switched on and off.

What's harder to say honestly is how that change in serotonin translates into someone feeling less depressed or less anxious. For a long time the public explanation was the "chemical imbalance" story: depression is too little serotonin, an SSRI tops it up, and balance is restored. That story is too simple, and the field has moved on from it. The blocking of reuptake happens within hours of the first dose, but the clinical benefit takes weeks. That delay alone tells us the effect can't just be about serotonin levels in the synapse. Something slower has to be going on downstream.

The leading explanation is that raising serotonin sets off a chain of slower adaptations in the brain. Over weeks, the activity of serotonin receptors shifts, gene expression inside neurons changes, and the brain's capacity to form and reshape connections, often called neuroplasticity, appears to increase. Some researchers describe SSRIs less as drugs that directly lift mood and more as drugs that, over time, make the brain more able to change, with therapy, daily life, and recovery doing part of the work. There's also good evidence that SSRIs reduce activity in threat-related brain circuits and shift how a person processes negative information, which fits the way anxiety and low mood often ease before a person can name exactly what changed.

The honest summary is that SSRIs clearly help many people, we understand the first step of how, but the full biological account is still incomplete. A treatment can be effective and well evidenced even when the mechanism isn't fully mapped. It's worth saying plainly, because the old "low serotonin" line led some people to feel that taking an SSRI meant admitting to a permanent brain defect. It doesn't. It's a medication that nudges a complex system toward recovery.

What to expect, week by week

One of the most useful things to understand before starting an SSRI is the timeline, because the order in which things happen can be confusing and even discouraging if no one explains it. The short version: side effects, if they come, tend to show up first, and the benefit comes later. Knowing that in advance makes the early stretch much easier to sit through.

The first days to a week. This is when mild early side effects are most likely to appear. Nausea is the most common, and it's usually mild and tied to taking the medication on an empty stomach. Headache, looser stools, a bit of jitteriness or restlessness, changes in sleep, and a sense of feeling slightly "off" can also turn up. For people taking an SSRI for an anxiety condition, a brief uptick in anxiety in the first days is common enough that prescribers often start at a low dose specifically to soften it. What almost never happens in this window is a lift in mood. If anything, the first week can feel like the medication is only causing problems. That's expected. It's the body adjusting, not the treatment failing. Most of these early effects ease within a week or two as the body settles.

Weeks two to four. This is the early-change window. The harshest of the start-up side effects usually fade. Some people begin to notice small shifts: sleep steadies a little, the morning feels slightly less heavy, the constant edge of worry loosens its grip a notch, or other people comment that they seem more like themselves before the person notices it directly. These early changes are often subtle and easy to miss or dismiss. They tend to show up in functioning, getting through the day with a bit less effort, before they show up as a clear feeling of "better." Not everyone notices anything by week four, and that alone doesn't mean the medication won't work.

Weeks four to eight. This is when the fuller benefit usually arrives. For depression and for the anxiety conditions, the more complete therapeutic effect commonly builds over roughly four to eight weeks, sometimes longer, and OCD in particular can take longer still and may need a higher dose. By the end of this window a prescriber and patient can usually tell whether the medication, at an adequate dose and given a fair trial, is helping enough. If it isn't, that's the point where a prescriber may raise the dose or consider switching. Giving up before a fair trial is over is one of the most common reasons a workable medication gets abandoned, which is why understanding this timeline matters so much.

A few honest qualifiers sit alongside this. People vary, and some feel benefit sooner while others take longer. The first SSRI tried doesn't always turn out to be the right one, and needing to adjust the dose or switch is common, not a sign that medication won't work for you. The pattern above is reliable in shape, less so in exact timing.

Who they're for and what they treat

SSRIs are among the most broadly useful medications in psychiatry, which is part of why they're prescribed so widely. They're a first-line option across several conditions.

Depression. SSRIs are a first-line medication for major depressive disorder, supported by a very large body of randomized trials and by guidelines from NICE, the American Psychiatric Association, and others. For mild depression, therapy or watchful waiting may be tried first; for moderate to severe depression, an SSRI is a standard choice, often alongside therapy. There's an important step that should happen before any antidepressant is started for depression: the prescriber screens for bipolar disorder. That means asking about any past periods of unusually elevated, energized, or irritable mood, racing thoughts, or a sharply reduced need for sleep. The reason is practical and important. In someone who actually has bipolar disorder, an antidepressant given on its own can sometimes destabilize mood or trigger a switch into a high or mixed state. Bipolar depression is treated differently from unipolar depression, so getting this distinction right before prescribing genuinely changes the plan. The screening question isn't a formality.

Anxiety disorders. SSRIs are first-line for generalized anxiety disorder, panic disorder, and social anxiety disorder, again supported by trials and guidelines. For anxiety, prescribers often start at a lower dose than they might for depression, because the brief early jitteriness can be more pronounced in already-anxious people, and starting low softens it.

Obsessive-compulsive disorder. SSRIs are an evidence-based first-line medication for OCD. Two things tend to differ here. OCD often needs higher doses than depression does, and the response can take longer to build, sometimes ten to twelve weeks or more. SSRIs for OCD work best paired with a specific form of therapy, exposure and response prevention.

Post-traumatic stress disorder. SSRIs are a recommended medication option for PTSD, and certain SSRIs carry specific regulatory approval for it. Trauma-focused therapy is also a core treatment, and the two are often combined.

Premenstrual dysphoric disorder. SSRIs are an effective treatment for PMDD, the severe mood form of premenstrual symptoms. PMDD is one situation where SSRIs can sometimes work quickly, and they're used in more than one pattern: continuously through the month, or only during the luteal phase, the roughly two weeks before a period. The right pattern is decided with a prescriber.

What ties the list together is that these are conditions where serotonin-acting medication has a real, evidence-backed role, and where an SSRI is a reasonable, well-studied place to start.

Side effects and safety

This is the section to read slowly. SSRIs are generally well tolerated, and most people who take them do fine, but "well tolerated" isn't the same as "no downsides." An honest account of the side effects and the safety topics is what lets a person and a prescriber make a real decision, weigh things sensibly, and know what to watch for. Drug-by-drug specifics, since the individual SSRIs differ, are covered at PsychiatryRx.org. What follows is the picture for the class.

### Common side effects

Most common side effects are mild, show up early, and ease over the first couple of weeks as the body adjusts. The frequent early ones are nausea, headache, looser stools or stomach upset, and a bit of restlessness or jitteriness. Taking the medication with food often helps the nausea. These start-up effects are usually the price of the first week or two, not a permanent state.

A few side effects deserve closer attention because they can persist and because people often don't raise them on their own.

Sexual side effects. This is the most common persistent side effect of SSRIs, and the one most often left unspoken. SSRIs can reduce sexual desire, make arousal harder, and delay or block orgasm, in people of any gender. Unlike the early nausea, these effects often don't fade with time on the medication. They matter, they affect quality of life and relationships, and they're a frequent reason people quietly stop taking a medication that's otherwise helping. None of that needs to happen in silence. Sexual side effects are a normal thing to raise with a prescriber, and there are real options: adjusting the dose, switching to a different antidepressant that's less likely to cause them, timing, or adding another medication. A prescriber can't help with a problem they don't know about.

Weight changes. SSRIs can be associated with weight change over time, more often modest weight gain, though the picture varies by individual and by drug. Some of this can also reflect appetite returning as depression lifts, which is recovery rather than a side effect. If weight change is bothersome or significant, it's worth a conversation rather than an assumption.

Sleep changes. SSRIs can disturb sleep in either direction. Some people feel more activated and sleep less, especially early on; others feel drawn toward more sleep or drowsiness. The drugs differ in which way they tend to push, and timing the dose differently, morning versus evening, sometimes helps. A prescriber can adjust for this.

Emotional blunting. Some people on SSRIs describe a narrowing of emotional range: a sense that the lows are lifted but the highs are also muted, or that they feel less moved by things than they expect to. This is genuinely reported and worth taking seriously. It's also not universal, and it's important not to confuse it with the depression itself, which flattens emotion too. For many people the effect of a working SSRI is the opposite of blunting: emotions become more manageable rather than muted, and people describe feeling more like themselves. When blunting does happen, it's usually something a prescriber can address by adjusting the dose or switching. It shouldn't be something a person just endures.

### Important safety topics

These are the topics that matter most to understand clearly. None of them is a reason for blanket fear. Each one is a reason to take SSRIs seriously, use them with a prescriber, and know what to watch for.

Discontinuation and withdrawal effects. Stopping an SSRI suddenly, or sometimes even missing several doses, can cause discontinuation symptoms. These can include dizziness, flu-like feelings, irritability, trouble sleeping, vivid dreams, and brief electric-shock-like sensations sometimes called "brain zaps." Discontinuation effects are real, and for some people they're significant and last longer than the brief course once assumed. They're more likely with SSRIs that leave the body quickly and less likely with longer-acting ones. This isn't the same as addiction, and the difference matters. There's no craving and no drive to take more. It's the body readjusting to the absence of a drug it had adapted to. The practical point is simple: SSRIs are stopped gradually, with a taper planned by a prescriber, not stopped cold.

The FDA boxed warning on suicidal thoughts in people under 25. SSRIs carry a boxed warning, which is the US Food and Drug Administration's most prominent safety warning. It notes an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults up to age 25, particularly early in treatment and after a dose change. A few things make this easier to understand. The increased risk concerns suicidal thoughts and behavior, and the warning was based on short-term trial data; it didn't show an increase in completed suicide, and untreated depression itself carries a serious risk of suicide. The warning's real message is about monitoring, not avoidance. It's the reason a prescriber should check in closely with younger patients in the first weeks and after any dose change, and the reason families should know to watch for worsening mood, agitation, or new thoughts of self-harm and to make contact quickly if they see them. For many young people, treating the depression or anxiety is the right and necessary choice. The warning makes that treatment safer by building in vigilance. It's something to discuss openly with a prescriber.

Serotonin syndrome. This is a rare but serious reaction that happens when there's too much serotonin activity in the body, most often when an SSRI is combined with another drug that also raises serotonin. The list of such drugs is longer than people expect: other antidepressants, certain migraine medications, tramadol, the supplement St. John's wort, some recreational drugs, and others. Symptoms can include agitation, confusion, a fast heartbeat, high blood pressure, heavy sweating, shivering, tremor, muscle twitching, and in severe cases high fever. Serotonin syndrome can range from mild to a medical emergency. The practical protection is straightforward: tell every prescriber and pharmacist about every medication and supplement you take, including over-the-counter ones, so dangerous combinations get caught. If symptoms like these appear after a new drug is added, it needs urgent medical attention.

Increased bleeding risk. SSRIs can slightly increase the tendency to bleed, because serotonin plays a role in how platelets help blood clot. On its own this is usually minor. It becomes more relevant when an SSRI is combined with other things that affect bleeding, particularly NSAID pain relievers such as ibuprofen and naproxen, aspirin, and blood thinners. The combination raises the risk of bleeding, including in the stomach. This doesn't mean these drugs can never be used together, but it's a real interaction a prescriber should know about, and it's worth asking before reaching regularly for an over-the-counter NSAID while on an SSRI.

Low blood sodium (hyponatremia). SSRIs can occasionally cause the blood sodium level to drop, a condition called hyponatremia. This is uncommon overall but more likely in older adults, in people on diuretics ("water pills"), and in the first weeks of treatment. Symptoms can be vague, headache, trouble concentrating, confusion, unsteadiness, and fatigue, and severe cases are dangerous. It's a particular reason for care and sometimes for a blood test when starting an SSRI in an older adult.

Pregnancy and breastfeeding. This is genuinely individual and belongs in a careful conversation with a prescriber, ideally before pregnancy when possible. The honest summary is that it's a balance, not a simple yes or no. Untreated depression or anxiety in pregnancy carries real risks for both parent and baby, so stopping a needed medication isn't automatically the safer choice. At the same time, SSRIs do cross the placenta, and some have been studied more than others, with certain SSRIs generally preferred in pregnancy. Use later in pregnancy can sometimes cause a baby to be jittery or have feeding or breathing difficulty for a short time after birth. SSRIs are generally considered compatible with breastfeeding, with some preferred over others. None of this is a decision to make alone or from a website. It's a decision to make with a prescriber who can weigh the specific medication, the specific situation, and the risks on both sides.

One closing word. The point of laying out the side effects and safety topics plainly isn't to frighten anyone away from a treatment that helps millions of people. It's that informed people make better decisions and have better conversations with their prescribers. An SSRI used thoughtfully, with monitoring and honest two-way communication, is a safe and effective treatment for most people who need one.

Starting, changing, and stopping

Every part of an SSRI's life cycle belongs with a prescriber. That's not a legal disclaimer. It's the practical reality of how these medications work safely.

Starting. Prescribing an SSRI well begins with an assessment: what's being treated, whether medication fits, whether bipolar disorder has been screened for, what other medications and supplements the person takes, and any medical conditions that matter. From there, prescribers usually start at a low dose and increase it gradually if needed. Starting low softens the early side effects and the brief jitteriness, especially for anxiety. The early weeks include check-ins, more frequent for younger patients, to track side effects, watch for any worsening mood or new thoughts of self-harm, and see whether the medication is helping. An SSRI bought, borrowed, or shared without this process skips the parts that make it safe.

Changing. If a first SSRI doesn't help enough after a fair trial at an adequate dose, that's common and not a dead end. A prescriber may raise the dose, switch to a different SSRI, switch to a different class, or add something. The first medication tried isn't always the right one, and finding the fit can take a round or two. Switching between antidepressants has to be done carefully, because of timing and interaction issues, which is another reason it isn't a do-it-yourself task.

Stopping. Many people take an SSRI for a defined period. For a first episode of depression, guidelines often suggest continuing for several months after a person feels well, frequently around six months or more, to lower the chance of relapse; for recurrent depression or for some anxiety conditions, longer treatment may make sense. When the time comes to stop, it's done by tapering the dose down gradually on a schedule the prescriber sets, sometimes over weeks or longer, to reduce discontinuation symptoms. Stopping abruptly is the main avoidable cause of a rough discontinuation experience. The single most important rule here: don't stop an SSRI on your own, even if you feel better, and especially not suddenly. Feeling better is often a sign the medication is working, not a sign it's no longer needed. Talk to the prescriber, and stop the way they guide you to.

What the evidence shows

SSRIs are among the most studied medications in all of psychiatry, tested in a very large number of randomized controlled trials over several decades and assessed in major guidelines and systematic reviews. The broad picture is consistent.

• They work for depression. Across controlled trials, SSRIs reduce depressive symptoms more than placebo, and they're recommended as a first-line medication in guidelines from NICE, the American Psychiatric Association, and others. The benefit is clearer in moderate to severe depression than in mild depression, where therapy or watchful waiting is often reasonable first.
• They work for anxiety disorders. SSRIs reduce symptoms more than placebo in generalized anxiety disorder, panic disorder, and social anxiety disorder, and they're first-line for these conditions in major guidelines.
• They work for OCD, PTSD, and PMDD. SSRIs have an established, evidence-based role in all three, with the OCD response often needing higher doses and more time.
• They're generally well tolerated. Compared with the older tricyclic antidepressants, SSRIs cause fewer dangerous side effects and are far safer in overdose, which is a large part of why they replaced the older drugs as the default.
• Therapy and medication are both effective, and combining them helps. For depression and anxiety, psychotherapy such as CBT and medication each help a substantial share of people, and for more severe or stubborn cases combining them often does better than either alone.

A few honest qualifications belong here too. The size of the average benefit over placebo has been debated, partly because placebo response is high in depression trials, and the benefit is most convincing in more severe illness. Trials measure averages, and an average doesn't predict any one person's result. And the research is better at showing that SSRIs help than at predicting which person will respond to which drug. None of that undercuts the core finding: SSRIs are an effective, well-evidenced, first-line treatment. It just means they're a tool used with judgment, monitoring, and follow-up, not a guaranteed fix applied the same way to everyone.

What to ask your prescriber

If you're considering an SSRI, or already taking one, these questions can make the conversation more useful:

• Why this medication for me, and what are we hoping it will treat?
• How long until I'd expect to notice a benefit, and how will we know if it's working?
• What side effects should I watch for early, and which ones tend to fade?
• What should I do if I get sexual side effects, or feel emotionally flat?
• Have we screened for bipolar disorder before starting this?
• What other medications, supplements, or over-the-counter drugs should I avoid or be careful with?
• Is it safe to take ibuprofen or other NSAIDs while I'm on this?
• How long would you expect me to stay on it, and how would we stop safely when the time comes?
• What should I do if I miss a dose, or run out?
• Who do I contact, and how, if my mood gets worse or I have thoughts of self-harm in the first weeks?